1 |
Yamamoto M, Sugimoto T. Advanced glycation end pro-ducts, diabetes, and bone strength[J]. Curr Osteoporos Rep, 2016, 14(6): 320-326.
|
2 |
Heilmeier U, Patsch JM. Diabetes and bone[J]. Semin Musculoskelet Radiol, 2016, 20(3): 300-304.
|
3 |
Paschou SA, Dede AD, Anagnostis PG, et al. Type 2 diabetes and osteoporosis: a guide to optimal management[J]. J Clin Endocrinol Metab, 2017, 102(10): 3621-3634.
|
4 |
Wen J, Liu QJ, Liu MM, et al. Increasing imbalance of Treg/Th17 indicates more severe glucose metabolism dys-function in overweight/obese patients[J]. Arch Med Res, 2021, 52(3): 339-347.
|
5 |
Zhu L, Hua F, Ding WG, et al. The correlation between the Th17/Treg cell balance and bone health[J]. Immun Ageing, 2020, 17: 30.
|
6 |
Dodd GT, Lee-Young RS, Brüning JC, et al. TCPTP re-gulates insulin signaling in AgRP neurons to coordinate glucose metabolism with feeding[J]. Diabetes, 2018, 67(7): 1246-1257.
|
7 |
Parlato M, Nian Q, Charbit-Henrion F, et al. Loss-of-function mutation in PTPN2 causes aberrant activation of JAK signaling via STAT and very early onset intestinal inflammation[J]. Gastroenterology, 2020, 159(5): 1968-1971.e4.
|
8 |
Wang YN, Jia TT, Zhang JJ, et al. PTPN2 improves implant osseointegration in T2DM via inducing the dephosphorylation of ERK[J]. Exp Biol Med (Maywood), 2019, 244(16): 1493-1503.
|
9 |
Spalinger MR, Kasper S, Chassard C, et al. PTPN2 controls differentiation of CD4⁺ T cells and limits intestinal inflammation and intestinal dysbiosis[J]. Mucosal Immunol, 2015, 8(4): 918-929.
|
10 |
Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications[J]. Nat Rev Endocrinol, 2018, 14(2): 88-98.
|
11 |
杨文英. 中国糖尿病的流行特点及变化趋势[J]. 中国科学(生命科学), 2018, 48(8): 812-819.
|
|
Yang WY. Epidemiology and trends in diabetes in China[J]. Sci China (Series C), 2018, 48(8): 812-819.
|
12 |
Yin YQ, Hao HJ, Cheng Y, et al. Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice[J]. Cell Death Dis, 2018, 9(7): 760.
|
13 |
Zhang CP, Xiao CC, Wang P, et al. The alteration of Th1/Th2/Th17/Treg paradigm in patients with type 2 diabetes mellitus: relationship with diabetic nephropathy[J]. Hum Immunol, 2014, 75(4): 289-296.
|
14 |
Samuel RO, Ervolino E, de Azevedo Queiroz ÍO, et al. Th1/Th2/Th17/treg balance in apical periodontitis of nor-moglycemic and diabetic rats[J]. J Endod, 2019, 45(8): 1009-1015.
|
15 |
Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation pro-gram of proinflammatory IL-17+ T helper cells[J]. Cell, 2006, 126(6): 1121-1133.
|
16 |
Ibarra-Sánchez MJ, Simoncic PD, Nestel FR, et al. The T-cell protein tyrosine phosphatase[J]. Semin Immunol, 2000, 12(4): 379-386.
|
17 |
van Vliet C, Bukczynska PE, Puryer MA, et al. Selective regulation of tumor necrosis factor-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase[J]. Nat Immunol, 2005, 6(3): 253-260.
|
18 |
Li Y, Zhou HM, Wang F, et al. Overexpression of PT-PN2 in visceral adipose tissue ameliorated atherosclerosis via T cells polarization shift in diabetic apoe-/- mice[J]. Cell Physiol Biochem, 2018, 46(1): 118-132.
|